LONGEFI
Science · Developing

Senolytics

Senescent cells accumulate with age and secrete inflammatory factors. Senolytics aim to remove them selectively. The field's challenge has been achieving selectivity without systemic toxicity.

Latest research

SenolyticsJAMA Ophthalmology · 9 Aug 2026
Signal74·Notable

Senolytic eye therapy holds effect at 36 weeks in Phase 2b

A locally delivered senolytic maintained vision gains at 36 weeks in diabetic macular edema, with fewer re-injections than standard anti-VEGF therapy.…

EvidenceModerateMarket relevanceMedium5 min read